Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine
Status:
Active, not recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Capecitabine is a chemotherapy drug used to treat many types of cancer including bowel and
stomach cancer. Unfortunately a side effect of this drug is that it causes heart problems
including heart attacks. An alternative drug, called teysuno is used extensively in other
countries instead of capecitabine and appears to have less of a bad effect on the heart
whilst still killing cancer cells. This study will investigate the effect of these two drugs
on the heart and blood vessels and will be the first of its kind in humans.